Innovation Agency exceeds national stroke prevention targets
Around 80 strokes will be prevented in the North West Coast each year thanks to a programme to detect and treat irregular heart rhythms.
The Innovation Agency, the Academic Health Science Network for the North West Coast, has exceeded its targets to detect people in the region with atrial fibrillation (AF).
AF is responsible for approximately 20 per cent of all strokes, which can leave survivors with devastating disabilities. In the UK, one million people are known to be affected by AF and an additional 422,600 people are undiagnosed. Treating the condition costs the NHS over £2.2 billion each year.
Making sure people with AF are given the best treatment – usually blood-thinning medication to prevent clots (anticoagulants) – can more than halve their risk of having a stroke.
In 2015, the Academic Health Science Network set ambitious targets to improve the detection, diagnosis and treatment of patients with AF.
Here in the North West Coast, data showed that:
- 24,210 people were estimated to have undetected AF
- 76 per cent of people with high-risk AF were treated with anticoagulation therapy
The Innovation Agency played a key role in the nationwide ‘Detect, Protect, Perfect’ campaign and was tasked with detecting and diagnosing 85 per cent of those ‘missing’ people with undiagnosed AF and ensuring 84 per cent of patients with AF, known to be at high risk of a stroke, were adequately anticoagulated.
The latest Quality Outcome Framework (QOF) data for 2018/2019 revealed that the Innovation Agency achieved a 98 per cent detection rate against a Public Health England target of 85 per cent, making it the highest performing region for this national programme and exceeding the national target for 2029.
Plus, 84 per cent of our region’s high-risk AF patients are now receiving anticoagulation therapy – an increase of eight per cent since 2015/2016.
The Innovation Agency adopted a partnership approach to engage the whole healthcare system in helping to detect people with AF and improve care. It has:
- Distributed over 500 mobile ECG devices to healthcare teams across primary care and community services to facilitate opportunistic pulse testing
- Trained over 70 volunteer AF Ambassadors to test pulses in their communities
- Trained fire and rescue services in Cheshire, Merseyside, Lancashire and Cumbria to perform pulse checks during community safe and well visits, resulting in over 10,000 opportunistic pulse tests and over 1,000 people being signposted for further investigation
- Implemented two AF Collaboratives involving 136 GP practices and nine CCGs to deliver a quality improvement programme to primary care. This has resulted in 2,300 people being diagnosed with AF and given anticoagulation therapy
This collaborative approach has demonstrated significant, sustainable improvement in the detection and management of AF for the region.
Dr Julia Reynolds, Associate Director and Head of Programmes at the Innovation Agency, said: “We are delighted that all the hard work in our region in testing pulses, has resulted in more people being identified with AF and treated to prevent potential strokes. We have already started to see a reduction in AF-related strokes.”
If you would like to find out more contact Julia on 01772 520 253 or email Julia.Reynolds@innovationagencynwc.nhs.uk
Latest News from
New chief exec for Innovation Agency26/10/2020 12:25:00
The Innovation Agency has appointed Dr Phil Jennings as chief executive, four years after he joined the organisation as medical director, later becoming deputy chief executive.
Facemask manufacturing facility launched by family business in Lancashire26/10/2020 10:15:00
A manufacturing facility for civilian and surgical masks has been launched by Lancashire family business Issa Group. The new facility, Walton Mill, is based in the heart of Lancashire.
NHS trusts and suppliers in the North receive awards for response to COVID-1926/10/2020 09:15:00
An NHS trust and two innovative suppliers claimed top honours at this year’s NHS in the North Excellence in Supply Awards.
Business leader to head SEED healthcare alliance in Lancashire and South Cumbria22/10/2020 09:10:00
The former managing director of BAE Systems Corporate Services, Steve Fogg, has been appointed as chair of the SEED alliance - a multi-sector collaborative set up to contribute to ‘health and wealth’ in Lancashire and South Cumbria.
Safer care during COVID-1909/10/2020 09:10:00
The AHSN Network, of which the Innovation Agency is a part, has published a rapid-learning report on the role of Patient Safety Collaboratives (PSCs) during the pandemic.
Local NHS ‘innovation hubs’ to be created06/10/2020 12:25:00
The Innovation Agency and fellow AHSNs are supporting a new national funding initiative led by the Health Foundation, to support healthcare provider organisations to adopt innovation faster.
Collaboration to combat cholesterol06/10/2020 09:10:00
A project is under way in the North West Coast to tackle the potentially fatal condition of high cholesterol.
A ‘curious experiment’ – how the Innovation Agency began05/10/2020 09:10:00
A new report from The King’s Fund explores the evolution of the Innovation Agency since it began seven years ago as ‘a curious experiment’.